Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwarz Bioresearch was a pioneering American biotechnology company specializing in the production of high-purity biochemicals, including nucleic acids, amino acids, and radiolabeled compounds. Founded in the 1940s as a division of Schwarz Laboratories, the company became a critical supplier to the global research community, facilitating significant advancements in molecular biology and biochemistry. It is notably recognized for being the first to commercially offer radiolabeled biochemicals, which were essential for tracing metabolic pathways in scientific research. In 1970, the company was acquired by Becton Dickinson and merged with Mann Research Laboratories to form the Schwarz/Mann division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwarz Bioresearch.